Skip to main content
. 2022 Aug 26;106(18):5863–5877. doi: 10.1007/s00253-022-12135-2

Fig. 3.

Fig. 3

Challenges that needs to be resolved before PAC-MAN could be used therapeutically. These challenges include a need suitable delivery tool, immunologic effects of cas proteins, interfere of secondary structure of RNA and expression